AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15164111
Drug: Cow's milk
RxNorm normalized name: Cow's milk
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cow's milk consumption <500 g/day
Trial: 8308770
Drug: Nonsteroidal antiinflammatory
RxNorm normalized name: Arthriten Inflammatory Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsteroidal antiinflammatory drug (NSAID) therapy
Trial: 2962333
Drug: Nebulised ipratropium
RxNorm normalized name: Ipratropium
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulised ipratropium bromide 0.05 mg
Trial: 2962333
Drug: Nebulised ipratropium
RxNorm normalized name: Ipratropium
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulised ipratropium bromide 0.5 mg
Trial: 2962333
Drug: Salbutamol 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol 0.25 mg
Trial: 2962333
Drug: Salbutamol 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol 2.5 mg
Trial: 20399986
Drug: rosuvastatin 10
RxNorm normalized name: rosuvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin 10 mg/d plus telmisartan 80 mg/d (RT group)
Trial: 20399986
Drug: rosuvastatin 10
RxNorm normalized name: rosuvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin 10 mg/d plus irbesartan 300 mg/d (RI group)
Trial: 20399986
Drug: rosuvastatin 10
RxNorm normalized name: rosuvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin 10 mg/d plus olmesartan 20 mg/d (RO group)
Trial: 25271389
Drug: Parenteral nutritional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral nutritional support
Trial: 8844448
Drug: Orlistat (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat (120 mg three times daily for 9 days)
Trial: 6406586
Drug: Nitroglycerin (acute
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin (acute therapy)
Trial: 6406586
Drug: Nitroglycerin (sustained
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin (sustained therapy)
Trial: 31201876
Drug: Immediate-release morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release morphine as needed
Trial: 31201876
Drug: Titration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Titration of morphine
Trial: 31201876
Drug: Titrate baseline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Titrate baseline oxycodone
Trial: 31201876
Drug: Stepwise switch
RxNorm normalized name: Witch Hazel
DrugBank: Witch hazel (DB11111)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stepwise switch to morphine
Trial: 31201876
Drug: Add morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Add morphine on baseline oxycodone
Trial: 31201876
Drug: Add morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Add morphine on baseline fentanyl
Trial: 20111849
Drug: Intramuscular botulinum
RxNorm normalized name: Clostridium botulinum
DrugBank: Clostridium botulinum (DB14223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular botulinum toxin‐A (Dysport 500‐1000U)
Trial: 15692475
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone (200 mg once weekly, 5 40‐mg tablets)
Trial: 10649166
Drug: Intravenous immune
RxNorm normalized name: Intravenous immune globulin (human)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immune globulin (1 g/kg body weight) for 2 consecutive days each month until 36 weeks' gestation
Trial: 9153784
Drug: Methanol administered
RxNorm normalized name: methanol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methanol administered orally at a dose of 10 mg/kg
Trial: 9153784
Drug: Methanol administered
RxNorm normalized name: methanol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methanol administered intravenously at a dose of 10 mg/kg
Trial: 8475628
Drug: Hypokinesia with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypokinesia with daily fluid and salt supplements (water 26 ml/kg body weight and sodium chloride 0.16 g/kg body weight)
Trial: 3895186
Drug: Carotenoid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carotenoid treatment (100 mg daily of betacarotene and canthaxanthine)
Trial: 3895186
Drug: Oxychloroquine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxychloroquine treatment (200 mg daily)
Trial: 8327167
Drug: Propofol (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (intravenous anesthetic)
Trial: 12972520
Drug: Exisulind 125
RxNorm normalized name: Exisulind
DrugBank: Exisulind (DB06246)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exisulind 125 mg orally bid in combination with capecitabine 2,000 mg/m2 for 14 days in 21-day cycles
Trial: 12972520
Drug: Exisulind 125
RxNorm normalized name: Exisulind
DrugBank: Exisulind (DB06246)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exisulind 125 mg orally bid
Trial: 8840343
Drug: Amitriptyline 30
RxNorm normalized name: amitriptyline 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline 30 mg/day
Trial: 8840343
Drug: Flupentixole 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flupentixole 1.5 mg/day
Trial: 8840343
Drug: Clotiazepam 15
RxNorm normalized name: clotiazepam
DrugBank: Clotiazepam (DB01559)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clotiazepam 15 mg/day
Trial: 8840343
Drug: Meta-analysis of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meta-analysis of all agents
Trial: 1634784
Drug: Diazepam (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (0.1 mg/kg) followed by placebo (0.5 mg/kg as bolus and 0.5 mg/kg/hour infusion)
Trial: 1634784
Drug: Diazepam (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (0.1 mg/kg) followed by ketamine (0.5 mg/kg as bolus and 0.5 mg/kg/hour infusion)
Trial: 30424786
Drug: GSK1120360A (prolyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK1120360A (prolyl hydroxylase inhibitor)
Trial: 30424786
Drug: Daprodustat (clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daprodustat (clinical prolyl hydroxylase inhibitor)
Trial: 25448495
Drug: Gabapentin (GBP)
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gabapentin (GBP) administered 1 hour before surgery
Trial: 19844694
Drug: 0.5 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g/kg fish oil (FO) 1 day before LPS
Trial: 19844694
Drug: 0.2 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 g/kg fish oil (FO) 1 day before LPS
Trial: 19844694
Drug: 0.2 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 g/kg fish oil (FO) 2 hours before LPS
Trial: 14704377
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group (case managers with risk and benefit information)
Trial: 10546917
Drug: LI160 (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LI160 (900 mg/d)
Trial: 8914412
Drug: Topical corticosteroid
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical corticosteroid (fluticasone propionate; Flunase) and antiallergic medicine (azelastin) administered 4 weeks before pollen season (Group A)
Trial: 8914412
Drug: Antiallergic medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiallergic medicine (azelastin) administered at the same time as Group A, with topical corticosteroid given after symptoms appeared (Group B)
Trial: 8914412
Drug: Topical corticosteroid
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical corticosteroid (fluticasone propionate; Flunase) in Group A
Trial: 1854375
Drug: Alcohol (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (0.25 g/kg‐1 g/kg)
Trial: 6587183
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of surgery and adjuvant chemotherapy
Trial: 26920949
Drug: Acotiamide (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acotiamide (300 mg/day) and rabeprazole (10 mg/day) combination therapy
Trial: 26920949
Drug: Acotiamide (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acotiamide (300 mg/day)
Trial: 22721612
Drug: Intravenous glutamate
RxNorm normalized name: glutamate
DrugBank: Leucovorin (DB00650)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous glutamate infusion
Trial: 14586388
Drug: Intranasal methamphetamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal methamphetamine
Trial: 14586388
Drug: Intravenous methamphetamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous methamphetamine
Trial: 30569083
Drug: Pimavanserin 34
RxNorm normalized name: pimavanserin 34 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pimavanserin 34 mg daily for 12 weeks
Trial: 25459391
Drug: Gemcitabine 1000mg/m²
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine 1000mg/m² plus trastuzumab (8mg/kg loading dose, then 6 mg/kg every 21 days)
Trial: 23489705
Drug: Pidotimod 400
RxNorm normalized name: pidotimod 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pidotimod 400 mg, administered orally once a day for 90 days
Trial: 19189986
Drug: Ketamine 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.2 mg kg(‐1)
Trial: 15639698
Drug: Tazarotene 0.1%
RxNorm normalized name: TAZAROTENE 0.1% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tazarotene 0.1% cream QD for 12 weeks
Trial: 15639698
Drug: Vehicle cream
RxNorm normalized name: vehicle cream base no.160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle cream QD for 12 weeks
Trial: 12370877
Drug: Therapeutic combinations
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic combinations (B1: hot pack plus active ROM; B2: B1 plus ischemic compression; B3: B2 plus TENS; B4: B1 plus stretch with spray; B5: B4 plus TENS; B6: B1 plus interferential current and myofascial release)
Trial: 9440585
Drug: Heparin bonding
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin bonding
Trial: 31777236
Drug: Estazolam (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estazolam (oral tablets once a day for 4 weeks)
Trial: 27130075
Drug: Insulin treatment
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin treatment regimens (biphasic, aspart, detemir) in addition to metformin or placebo
Trial: 27130075
Drug: Weight gain
RxNorm normalized name: Nutritional Supplement Oral Powder for Suspension [MUSCLE & WEIGHT GAINER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight gain during the first 3 months of the trial and subsequent dose of insulin
Trial: 25468411
Drug: Capsaicin capsules
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Capsaicin capsules
Trial: 23308016
Drug: Losartan, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan, 100 mg (n=77)
Trial: 18097505
Drug: G. lucidum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G. lucidum extract (6 mg once a day)
Trial: 17038636
Drug: AHA step
RxNorm normalized name: PostDay One-Step
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: AHA step 1 diet plus simvastatin (40 mg/d)
Trial: 9210109
Drug: Computer reading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer reading treatment
Trial: 29346040
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (observation)
Trial: 29275607
Drug: Ketamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine infusion (0.5 mg/kg in 250 ml of 0.9% normal saline for 1 hour daily for 7 days)
Trial: 29275607
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (0.9% normal saline infusion)
Trial: 25010823
Drug: HME1L (Heat
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HME1L (Heat and Moisture Exchanger with low fresh gas flow 1 L·min)
Trial: 25010823
Drug: HME3L (Heat
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HME3L (Heat and Moisture Exchanger with high fresh gas flow 3 L·min)
Trial: 25010823
Drug: 1L (No
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1L (No Heat and Moisture Exchanger with low fresh gas flow 1 L·min)
Trial: 25010823
Drug: 3L (No
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3L (No Heat and Moisture Exchanger with high fresh gas flow 3 L·min)
Trial: 20137805
Drug: 8-week streptomycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8-week streptomycin (15 mg/kg once daily) and oral rifampicin (10 mg/kg once daily) for 8 weeks
Trial: 20137805
Drug: 4-week streptomycin
RxNorm normalized name: milnacipran
DrugBank: Milnacipran (DB04896)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 4-week streptomycin (15 mg/kg once daily) and oral rifampicin (10 mg/kg once daily) for 4 weeks followed by rifampicin and clarithromycin (7.5 mg/kg once daily) for 4 weeks
Trial: 17645253
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of Bushen Capsules (Control Group II)
Trial: 16098615
Drug: Isotonic Ems
RxNorm normalized name: ISOTON
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic Ems Mineral Salts (EMS) solution (1-2 sprays into each nostril t.d. for 14 days)
Trial: 16098615
Drug: Xylometazoline solution
RxNorm normalized name: XYLOMETAZOLINE
DrugBank: Xylometazoline (DB06694)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Xylometazoline solution (0.05%) (1-2 sprays into each nostril t.d. for 14 days)
Trial: 10449020
Drug: Hypertonic solution
RxNorm normalized name: Hypertonic solutions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic solution of lactulose
Trial: 2220621
Drug: Beta blockers
RxNorm normalized name: BETA BLOCKERS/RELATED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta blockers and enalapril
Trial: 7194082
Drug: BAY g
RxNorm normalized name: ALCOHOL 70 L in 100 L TOPICAL GEL [Victoria Bay Gel Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY g 5421 (3 x 100 mg)
Trial: 7194082
Drug: BAY g
RxNorm normalized name: ALCOHOL 70 L in 100 L TOPICAL GEL [Victoria Bay Gel Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY g 5421 (6 x 50 mg)
Trial: 7194082
Drug: Insulin, glucagon,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin, glucagon, lactate, triglyceride concentration (Control)
Trial: 7016781
Drug: BAY g
RxNorm normalized name: ALCOHOL 70 L in 100 L TOPICAL GEL [Victoria Bay Gel Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY g 5421
Trial: 25431105
Drug: Positive airway
RxNorm normalized name: VersaPAP Positive Airway Pressure Device
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive airway pressure treatment (adherent patients)
Trial: 25431105
Drug: Positive airway
RxNorm normalized name: VersaPAP Positive Airway Pressure Device
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive airway pressure treatment (non-users)
Trial: 23420314
Drug: Iontophoresis combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iontophoresis combined with local bath-PUVA therapy
Trial: 23420314
Drug: Local PUVA
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local PUVA therapy
Trial: 17173263
Drug: Peritoneal dialysis
RxNorm normalized name: Peritoneal dialysis solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peritoneal dialysis doses prescribed based on empirical criteria and urea kinetics model
Trial: 29574980
Drug: Ramipril (an
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril (an angiotensin-converting enzyme inhibitor)
Trial: 1835959
Drug: Candoxatril (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candoxatril (200 mg) on low sodium diet (10 mmol/day)
Trial: 1835959
Drug: Candoxatril (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candoxatril (200 mg) on high sodium diet (350 mmol/day)
Trial: 7104144
Drug: Propranolol (0.18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (0.18 mg/kg i.v.)
Trial: 7104144
Drug: Pindolol (0.023
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol (0.023 mg/kg i.v.)
Trial: 31427299
Drug: VL-2397 (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VL-2397 (3 mg to 1,200 mg single intravenous doses)
Trial: 31427299
Drug: VL-2397 (300,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VL-2397 (300, 600, and 1,200 mg intravenous doses every 24 hours for 7 days)
Trial: 31427299
Drug: VL-2397 (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VL-2397 (single doses >30 mg)
Trial: 30580349
Drug: Probiotics (lactobacillus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotics (lactobacillus rhamnosus 35) at a dose of 0.8 mg in infants >1500 gms and 0.4 mg in infants <1500 gms in 2 ml of expressed breast milk two times daily
Trial: 25603000
Drug: Amoxicillin‐clavulanate (40mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin‐clavulanate (40mg/kg per day for 7 days)
Trial: 23852661
Drug: Core decompression
RxNorm normalized name: diclofenac
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Core decompression and unprocessed bone marrow injection (group B)
Trial: 16846090
Drug: Electrical activation
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrical activation with 3 consecutive 40-/microsec pulses of 1.5 kV/cm direct electrical current in buffer solution
Trial: 9489070
Drug: Diclofenac sustained-released
RxNorm normalized name: diclofenac Delayed Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac sustained-released 75 mg tablets taken b.i.d.
Trial: 9489070
Drug: Diclofenac enteric-coated
RxNorm normalized name: diclofenac
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac enteric-coated 50 mg tablets given t.i.d.
Trial: 9489070
Drug: Diclofenac sustained-released
RxNorm normalized name: diclofenac Delayed Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac sustained-released 75 mg tablets
Trial: 9489070
Drug: Diclofenac enteric-coated
RxNorm normalized name: diclofenac
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac enteric-coated 50 mg tablets
Trial: 8251281
Drug: Doxapram 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxapram 1.5 mg kg‐1
Trial: 8251281
Drug: Pethidine 0.33
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pethidine 0.33 mg kg‐1
Trial: 30283171
Drug: Oral melatonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral melatonin 3 mg (2 tablets)
Trial: 30283171
Drug: Oral alprazolam
RxNorm normalized name: Alprazolam
DrugBank: Alprazolam (DB00404)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral alprazolam 0.25 mg (2 tablets)
Trial: 30283171
Drug: Placebo (multivitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (multivitamin tablet 2 tablets)
Trial: 27376373
Drug: Tocilizumab (TCZ)
RxNorm normalized name: Tocilizumab
DrugBank: Tocilizumab (DB06273)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tocilizumab (TCZ) intravenous/subcutaneous
Trial: 27376373
Drug: Tocilizumab (TCZ)
RxNorm normalized name: Tocilizumab
DrugBank: Tocilizumab (DB06273)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tocilizumab (TCZ) subcutaneous
Trial: 27376373
Drug: Tocilizumab (TCZ)
RxNorm normalized name: Tocilizumab
DrugBank: Tocilizumab (DB06273)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tocilizumab (TCZ) intravenous
Trial: 20595484
Drug: Topical nanofiber
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical nanofiber nitric oxide (NO) releasing patch (NOP)
Trial: 20595484
Drug: Intramuscular meglumine
RxNorm normalized name: Meglumine
DrugBank: Meglumine (DB09415)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular meglumine antimoniate (Glucantime)
Trial: 14732966
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of arnica and hydroxyethyl salicylate (HES) in ethanolic solution (Sportino Acute Spray)
Trial: 7806733
Drug: Katz Activities
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Katz Activities of Daily Living (ADL)
Trial: 7806733
Drug: Older Americans
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Older Americans Resources and Services Instrumental Activities of Daily Living (OARS-IADL)
Trial: 7154618
Drug: muzolimine (loop-diuretic)
RxNorm normalized name: hydralazine hydrochloride / hydrochlorothiazide / reserpine Oral Tablet [Diuretic Ap-Es]
DrugBank: Muzolimine (DB13801)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: muzolimine (loop-diuretic) for 6 weeks
Trial: 30659924
Drug: Genotype-tailored lansoprazole
RxNorm normalized name: Lansoprazole
DrugBank: Lansoprazole (DB00448)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Genotype-tailored lansoprazole daily for 24 weeks
Trial: 30659924
Drug: Conventional dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional dosing of open-label oral lansoprazole
Trial: 21739168
Drug: Cilengitide 2000
RxNorm normalized name: Cilengitide
DrugBank: Cilengitide (DB11890)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilengitide 2000 mg i.v. twice weekly after surgery
Trial: 21739168
Drug: Cilengitide 500
RxNorm normalized name: Cilengitide
DrugBank: Cilengitide (DB11890)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilengitide 500 mg i.v. (day -8, -4, -1)